711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda

Bibliographic Details
Main Authors:	Yun He, Juan Liu, Fei Chen, Yang Cao, Yuntao Wu, Lei Niu, Shuang Lu, Shaoping Hu, Xin Gan, Yongqiang Wang, Chuchu Zhao, Yi Ding, Jinqiu He, Qing Du, Xiaocheng Lv, Beibei Qin, Yuandong Wang, Yunxing Yang, Musheng Bao, Jason Noon, Wenhao Yu, Joe Zhao, Yiping Rong
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items